Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections
Runchu Zhao(Chinese Academy of Sciences), Qihui Wang(Shanxi Agricultural University), Yanli Xu(Capital Medical University), Han Wang(Peking University), Zhihai Chen(Capital Medical University), Junqing Sun(University of California, Davis), Yi Zhang(Soochow University), Lili Wu(Chinese Academy of Sciences), Dezhi Liu(Johns Hopkins University), Yue Gao(Chinese Academy of Sciences), Pu Han(Chinese Academy of Sciences), George F. Gao(Chinese Academy of Sciences), Xiao Qu(Chinese Academy of Sciences), Yan Chai(Chinese Academy of Sciences)
Cited by 38
Related Papers
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
|Trends in Microbiology|2016|3.1k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Viral targets for vaccines against COVID-19
|Nature reviews. Immunology|2020|1.1k